Sir
Your News Feature 'Standard model' (Nature 454, 682–685; 2008) highlights problems in using mice as models for human neurodegenerative disease. But these pitfalls may be widespread in animal research (see, for example, P. Perel et al. Br. Med. J. 334, 197; 2007).
Animal studies are not always well designed and null results are rarely published. The standards should be raised to be comparable to those already established in clinical research. Preclinical research projects using animals should be prospectively registered and systematically reviewed. Also, they should be properly designed by using randomization, adequate sample sizes and blinding for evaluation of outcome.
Any rigorous scientific research requires investigators to set their basic hypotheses in the context of what is already published, to avoid unnecessary replication and to justify the new study. However, there is often a failure in animal research to apply these standards. This can expose research volunteers and patients to flawed and inadequate research and put biotech investors at risk of substantial long-term financial loss.
Supporting the introduction of these requirements for animal research would improve the body of evidence available to policy-makers and investors with regard to human health. It would also minimize wastage of laboratory animals and improve patient safety.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
SABRE Research UK is a charity that raises awareness of these issues in animal research.
Additional information
Contributions may be sent to correspondence@nature.com.
Rights and permissions
About this article
Cite this article
Green, S. Animal research: raise standards to protect patients. Nature 455, 460 (2008). https://doi.org/10.1038/455460c
Published:
Issue Date:
DOI: https://doi.org/10.1038/455460c